Markus Follmann

3.1k total citations
62 papers, 700 citations indexed

About

Markus Follmann is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Oncology. According to data from OpenAlex, Markus Follmann has authored 62 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Public Health, Environmental and Occupational Health, 23 papers in Economics and Econometrics and 19 papers in Oncology. Recurrent topics in Markus Follmann's work include Clinical practice guidelines implementation (35 papers), Health Systems, Economic Evaluations, Quality of Life (23 papers) and Delphi Technique in Research (6 papers). Markus Follmann is often cited by papers focused on Clinical practice guidelines implementation (35 papers), Health Systems, Economic Evaluations, Quality of Life (23 papers) and Delphi Technique in Research (6 papers). Markus Follmann collaborates with scholars based in Germany, Canada and Italy. Markus Follmann's co-authors include I. Kopp, Achim Wöckel, Monika Nothacker, R. Kreienberg, Simone Wesselmann, Thomas Langer, Thorsten Kühn, Barbara Buchberger, Wolfgang Schmitt and Ullrich Graeven and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Epidemiology and British Journal of Cancer.

In The Last Decade

Markus Follmann

58 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Follmann Germany 14 284 149 118 117 99 62 700
Fiona McKenzie France 18 584 2.1× 109 0.7× 128 1.1× 130 1.1× 110 1.1× 31 1.0k
Christina A. Minami United States 13 256 0.9× 54 0.4× 102 0.9× 213 1.8× 81 0.8× 56 621
Scott R. Berry Canada 13 281 1.0× 72 0.5× 132 1.1× 55 0.5× 92 0.9× 30 497
Janine Ross United Kingdom 14 204 0.7× 95 0.6× 87 0.7× 98 0.8× 159 1.6× 24 1.1k
Mary C. Schroeder United States 15 333 1.2× 67 0.4× 83 0.7× 299 2.6× 150 1.5× 61 801
Simran Padam United States 7 266 0.9× 166 1.1× 161 1.4× 82 0.7× 133 1.3× 16 572
Safiya Karim Canada 16 428 1.5× 89 0.6× 93 0.8× 115 1.0× 273 2.8× 57 865
Cindy Geoghegan United States 10 338 1.2× 77 0.5× 71 0.6× 64 0.5× 120 1.2× 19 631
Luciana Neamţiu Italy 12 435 1.5× 99 0.7× 83 0.7× 101 0.9× 141 1.4× 46 823
Diana T. Chingos United States 8 278 1.0× 88 0.6× 77 0.7× 110 0.9× 117 1.2× 8 516

Countries citing papers authored by Markus Follmann

Since Specialization
Citations

This map shows the geographic impact of Markus Follmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Follmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Follmann more than expected).

Fields of papers citing papers by Markus Follmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Follmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Follmann. The network helps show where Markus Follmann may publish in the future.

Co-authorship network of co-authors of Markus Follmann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Follmann. A scholar is included among the top collaborators of Markus Follmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Follmann. Markus Follmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schäfer, Niklas, et al.. (2024). Barriers and facilitators of adherence to clinical practice guidelines in Germany—A systematic review. Journal of Evaluation in Clinical Practice. 31(3). e14173–e14173. 1 indexed citations
2.
Willis, Maria A., Stefan Post, Monika Nothacker, et al.. (2024). A methodological protocol for the development of a national guideline on perioperative management of gastrointestinal tumors in Germany. SHILAP Revista de lepidopterología. 13(1). 25–25. 1 indexed citations
3.
4.
Breuing, Jessica, Nadja Könsgen, Stefanie Bühn, et al.. (2024). Barriers and facilitators in developing patient versions of clinical practice guidelines - qualitative interviews on experiences of international guideline producers. BMC Health Services Research. 24(1). 78–78. 3 indexed citations
5.
Breuing, Jessica, Monika Becker, Stefanie Bühn, et al.. (2024). Use, applicability, and dissemination of patient versions of clinical practice guidelines in oncology in Germany: a qualitative interview study with healthcare providers. BMC Health Services Research. 24(1). 272–272. 1 indexed citations
6.
Breuing, Jessica, Nadja Könsgen, Stefanie Bühn, et al.. (2023). Heterogeneous methodology in the development of patient versions of clinical practice guidelines: a scoping review. Journal of Clinical Epidemiology. 161. 53–64. 5 indexed citations
7.
8.
Horn, Lars‐Christian, Matthias W. Beckmann, Markus Follmann, et al.. (2022). Revidierte Fassung der S3-Leitlinie Zervixkarzinom 2021 – Anforderungen an die Pathologie. PubMed. 43(4). 292–302. 2 indexed citations
9.
Piggott, Thomas, Miranda Langendam, Elena Parmelli, et al.. (2022). The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development. Journal of Clinical Epidemiology. 154. 197–203. 6 indexed citations
10.
Parmelli, Elena, Miranda Langendam, Thomas Piggott, et al.. (2021). Guideline-based quality assurance: a conceptual framework for the definition of key elements. BMC Health Services Research. 21(1). 173–173. 8 indexed citations
11.
Follmann, Markus, et al.. (2021). Guideline-Based Quality Indicators for Kidney and Bladder Cancer in Germany: Development and Implementation. Urologia Internationalis. 106(4). 360–367. 9 indexed citations
12.
Horn, Lars‐Christian, Anne Kathrin Höhn, Monika Hampl, et al.. (2020). S2k-Leitlinie Diagnostik und Therapie des Vaginalkarzinoms und seiner Vorstufen – Anforderungen an die Pathologie. Der Pathologe. 42(1). 116–124. 2 indexed citations
13.
Follmann, Markus. (2019). Leitlinieninitiativen der Europäischen Kommission. Forum. 34(2). 136–138.
14.
Weberschock, Tobias, et al.. (2016). Verbindlichkeit von Empfehlungsformulierungen in Leitlinien: Survey zur Wahrnehmung unter Leitlinienentwicklern. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 113. 1–8. 3 indexed citations
15.
Langer, Thomas & Markus Follmann. (2015). Das Leitlinienprogramm Onkologie (OL): Nukleus einer evidenzbasierten, patientenorientieren, interdisziplinären Onkologie?. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 109(6). 437–444. 9 indexed citations
16.
Kochs, Corinna, Markus Follmann, Simone Wesselmann, et al.. (2013). Development Process of Quality Indicators for the S3-Guideline Melanoma. Queensland's institutional digital repository (The University of Queensland). 11. 3–3. 2 indexed citations
17.
Kreienberg, R., Ute‐Susann Albert, Markus Follmann, et al.. (2013). Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer. Geburtshilfe und Frauenheilkunde. 73(6). 556–583. 41 indexed citations
18.
Huebner, Jutta & Markus Follmann. (2013). Complementary medicine in guidelines of the German Guideline Program in Oncology: comparison of the evidence base between complementary and conventional therapy. Journal of Cancer Research and Clinical Oncology. 139(9). 1481–1488. 15 indexed citations
19.
Follmann, Markus. (2012). Guidelines International Network (G-I-N) Conference 2012. Forum. 27(6). 427–430. 1 indexed citations
20.
Follmann, Markus, Lothar Heinemann, Anja Bauerfeind, & Edeltraut Garbe. (2000). Treatment with potentially hepatotoxic drugs and the risk of hepatocellular carcinoma: results of a european case - control study. Pharmacoepidemiology and Drug Safety. 9(5). 417–422. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fiona McKenzie Breakdown of academic impact, for papers by Christina A. Minami Breakdown of academic impact, for papers by Scott R. Berry Breakdown of academic impact, for papers by Janine Ross Breakdown of academic impact, for papers by Mary C. Schroeder Breakdown of academic impact, for papers by Simran Padam Breakdown of academic impact, for papers by Safiya Karim Breakdown of academic impact, for papers by Cindy Geoghegan Breakdown of academic impact, for papers by Luciana Neamţiu Breakdown of academic impact, for papers by Diana T. Chingos
Rankless by CCL
2026